Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0192 | 1 | 0.5 |
Chlamydia trachomatis | sulfite reductase | 0.0119 | 0.2407 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0192 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0097 | 0.0151 | 0.0151 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0192 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0192 | 1 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0192 | 1 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0192 | 1 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0192 | 1 | 0.5 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0192 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.017 | 0.7743 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0192 | 1 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0192 | 1 | 0.5 |
Leishmania major | p450 reductase, putative | 0.0192 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0192 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.017 | 0.7743 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0192 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 1 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0192 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0095 | 0 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0192 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0192 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0192 | 1 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0192 | 1 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0095 | 0 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0119 | 0.2407 | 0.2407 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0192 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0192 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0192 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Activity of the topoisomerase II dependent DNA cleavage; Inactive | ChEMBL. | 2542558 |
Fluoroscence (binding) | = 93.3 % | Percent fluoroscence of the ethidium bromide-DNA complex | ChEMBL. | 2542558 |
IC50 (functional) | = 41 ug ml-1 | Inhibition of KB cell growth in vitro | ChEMBL. | 2542558 |
T/C (functional) | NA 0 % | Median survival time per control mice with leukemia P388 at 400 mg/kg dose injected a dose of 400 mg/kg | ChEMBL. | 2542558 |
Unwinding (functional) | NT 0 ug ml-1 | Unwinding of DNA observed in a reaction mixture containing PBR322 DNA dimer, calf thymus DNA topoisomerase II, and the drug; (-) unwinding was not observed at 100 ug/mL of drug | ChEMBL. | 2542558 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.